Glucagon-like peptide 1 (GLP-1) receptor agonist: The gastrointestinal tract releases GLP-1, a major incretin, in response to glucose consumption
For cell viability, colony formation, and ROS-Glo assays, each independent biological experiment was performed in technical duplicates to ensure intra-experimental consistency
Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G
Q: How are B12 shots different from oral supplements
Proposed pathways include modulation of multiple neurotransmitter systems (influencing serotonin, dopamine, norepinephrine, GABA, glutamate levels), possible involvement of NMDA receptors, alpha-1 adrenergic signaling (e.g., potentiating pineal acetyltransferase activity), inhibition of somatostatin release via dopaminergic routes, reduced ACTH/cortisol for stress buffering, and stimulated growth hormone or somatoliberin secretion